Symbol: |
EPM2A
|
Description: |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) [Source:HGNC Symbol;Acc:3413]
|
Location: |
Chr6:145822719-146057160[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:180
Gene |
Compound |
Gen_sig |
Exp_pattern |
EPM2A |
NSC 677194 |
0.04 |
Down |
EPM2A |
NSC 677747 |
0.031 |
Down |
EPM2A |
NSC 678039 |
0.044 |
Up |
EPM2A |
NSC 678154 |
0.043 |
Down |
EPM2A |
Pyrimidin-2-amine, 4-(2-hydroxy-4-methoxyphenyl)-6-phenyl- |
0.013 |
Down |
EPM2A |
Pyrimidin-2-amine, 4-(2-hydroxy-4-methoxyphenyl)-6-phenyl- N-(phenylmethylene)- |
0.001 |
Down |
EPM2A |
NSC 679073 |
0.024 |
Up |
EPM2A |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.035 |
Up |
EPM2A |
NSC 681741 |
0.009 |
Up |
EPM2A |
NSC 682131 |
0.027 |
Down |
EPM2A |
5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- |
0.001 |
Up |
EPM2A |
Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- |
0.034 |
Down |
EPM2A |
NSC 684807 |
0.032 |
Down |
EPM2A |
Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- |
0.009 |
Down |
EPM2A |
Propanoic acid, 3,3,3-trifluoro- 2-[(4-fluorophenyl)amino]-2-[[(ethoxy)carbonyl]amino]-, ethyl ester |
0.015 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:42
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|